Estrogen receptors α and β -: Prevalence of estrogen receptor β mRNA in human vascular smooth muscle and transcriptional effects

被引:175
作者
Hodges, YK
Tung, L
Yan, XD
Graham, JD
Horwitz, KB
Horwitz, LD
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80262 USA
关键词
muscle; smooth; receptors; estrogen; coronary disease; human;
D O I
10.1161/01.CIR.101.15.1792
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Estrogens have vascular effects through the activation of estrogen receptors (ERs). In addition to ER alpha, the first ER to be cloned, a second subtype called ER beta has recently been discovered. Methods and Results-Using a reverse-transcriptase polymerase chain reaction assay that employs the same primer pair to simultaneously amplify ER alpha and ER beta transcripts, we found that ER beta is the ER form that is predominantly expressed in human vascular smooth muscle, particularly in women. The transcriptional effects of the 2 ERs in transfected HeLa cells differed. In response to 17 beta-estradiol, ER alpha is a stronger transactivator than ER beta at low receptor concentrations. However, at higher receptor concentrations, ER alpha activity self-squelches, and ER beta is a stronger transactivator. Tamoxifen has partial agonist effects with ER alpha but not with ER beta. Conclusions-The protective effects of estrogens in the cardiovascular system of women may be due to the genomic effects of ER beta in vascular tissue.
引用
收藏
页码:1792 / 1798
页数:7
相关论文
共 29 条
[1]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[2]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[3]   Differential expression of estrogen receptor-β (ERβ) in human pituitary tumors:: Functional interactions with ERα and a tumor-specific splice variant [J].
Chaidarun, SS ;
Swearingen, B ;
Alexander, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3308-3315
[4]   Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery [J].
Chen, SJ ;
Li, HB ;
Durand, J ;
Oparil, S ;
Chen, YF .
CIRCULATION, 1996, 93 (03) :577-584
[5]   Variant estrogen and progesterone receptor messages in human vascular smooth muscle [J].
Hedges, YK ;
Richer, JK ;
Horwitz, KB ;
Horwitz, LD .
CIRCULATION, 1999, 99 (20) :2688-2693
[6]   CANINE VASCULAR TISSUES ARE TARGETS FOR ANDROGENS, ESTROGENS, PROGESTINS, AND GLUCOCORTICOIDS [J].
HORWITZ, KB ;
HORWITZ, LD .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) :750-758
[7]   An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors [J].
Hovland, AR ;
Powell, RL ;
Takimoto, GS ;
Tung, L ;
Horwitz, KB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5455-5460
[8]   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613
[9]   Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice [J].
Iafrati, MD ;
Karas, RH ;
Aronovitz, M ;
Kim, S ;
Sullivan, TR ;
Lubahn, DB ;
ODonnell, TF ;
Korach, KS ;
Mendelsohn, ME .
NATURE MEDICINE, 1997, 3 (05) :545-548
[10]   Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells [J].
Inoue, S ;
Hoshino, S ;
Miyoshi, H ;
Akishita, M ;
Hosoi, T ;
Orimo, H ;
Ouchi, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (03) :766-772